167 related articles for article (PubMed ID: 36289663)
1. Anti-Cyclic Citrullinated Peptide Antibody Index in the Cerebrospinal Fluid for the Diagnosis and Monitoring of Rheumatoid Meningitis.
Caputi L; Boncoraglio GB; Bernardi G; Ciusani E; Dantes M; de Liso F; Erbetta A; Marucci G; Matinato C; Corsini E
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289663
[TBL] [Abstract][Full Text] [Related]
2. [Elevation of cerebrospinal fluid anti-cyclic citrullinated peptides antibody index is useful for rheumatoid meningitis preceding neurological symptoms without arthritis: a case report].
Yamaoka M; Izumi T; Eura N; Sasaki R; Kiriyama T; Sugie K
Rinsho Shinkeigaku; 2020 Sep; 60(9):631-635. PubMed ID: 32779602
[TBL] [Abstract][Full Text] [Related]
3. Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid Meningitis.
Nissen MS; Nilsson AC; Forsberg J; Milthers J; Wirenfeldt M; Bonde C; Byg KE; Ellingsen T; Blaabjerg M
Front Neurol; 2019; 10():666. PubMed ID: 31293505
[TBL] [Abstract][Full Text] [Related]
4. Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis.
Shibahara T; Matsushita T; Matsuo R; Fukushima Y; Fukuda K; Sugimori H; Kamouchi M; Kitazono T; Ago T
Case Rep Neurol; 2016; 8(2):156-160. PubMed ID: 27721779
[TBL] [Abstract][Full Text] [Related]
5. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
[TBL] [Abstract][Full Text] [Related]
6. Anti-streptavidin IgG antibody interference in anti-cyclic citrullinated peptide (CCP) IgG antibody assays is a rare but important cause of false-positive anti-CCP results.
Berth M; Willaert S; De Ridder C
Clin Chem Lab Med; 2018 Jul; 56(8):1263-1268. PubMed ID: 29466233
[TBL] [Abstract][Full Text] [Related]
7. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
Qu SJ; Ye H; Jia RL; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid meningitis in a patient with overlap syndrome: The usefulness of anti-citrullinated peptide antibodies determination in CSF.
Lorenzo-Barreto P; Roy-Ariño G; Pérez-Trapote F; Sáez-Marín A; Stiauren-Fernández ES; Zarza-Sanz B; García Barragán N; de la Puente-Bujidos C; Buisán-Catevilla FJ
Mod Rheumatol Case Rep; 2023 Jun; 7(2):347-349. PubMed ID: 36695557
[TBL] [Abstract][Full Text] [Related]
9. Anti-cyclic citrullinated Peptide antibody: an early diagnostic and prognostic biomarker of rheumatoid arthritis.
Manivelavan D; C K V
J Clin Diagn Res; 2012 Oct; 6(8):1393-6. PubMed ID: 23205355
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic utility of anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis].
Miyamura T; Watanabe H; Takahama S; Sonomoto K; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):102-9. PubMed ID: 19404008
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid meningitis without a history of rheumatoid arthritis: a case report and literature review.
Huang G; Wu L; Mei Z; Yao D
Rheumatol Int; 2023 Jun; 43(6):1173-1182. PubMed ID: 36125522
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics of psoriatic arthritis with positive rheumatoid factor or anti-cyclic citrullinated peptide antibody].
Dai LY; Gong DD; Zhao JX
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1008-1013. PubMed ID: 31848495
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis].
Spadaro A; Riccieri V; Alessandri C; Scrivo R; Valesini G
Reumatismo; 2006; 58(2):116-20. PubMed ID: 16829989
[TBL] [Abstract][Full Text] [Related]
14. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
16. Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients.
Zahran WE; Mahmoud MI; Shalaby KA; Abbas MH
Indian J Clin Biochem; 2013 Jul; 28(3):272-6. PubMed ID: 24426223
[TBL] [Abstract][Full Text] [Related]
17. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
[No Abstract] [Full Text] [Related]
18. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
19. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
20. A Case of Rheumatoid Meningitis Diagnosed with FLAIR Images and Anti-cyclic Citrullinated Peptide Antibodies Levels.
Suzuki T; Akamatsu Y; Oshida S; Sato S
NMC Case Rep J; 2024; 11():119-123. PubMed ID: 38756142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
